一个新发血栓调节蛋白相关凝血病家系:共遗传的TAFI缺陷部分减轻纤溶延迟
该研究报道一个携带新型THBD变异(预测p.Pro496Argfs*10)导致血栓调节蛋白相关凝血病(TM-AC)的家系,患者有异常出血、血浆TM水平大幅升高、凝血酶生成减弱和纤溶延迟。部分家系成员共遗传CPB2终止增益变异致TAFI缺陷,使纤溶延迟部分减轻但不影响凝血酶生成缺陷。
要点
- 新型THBD变异p.Pro496Argfs*10导致TM-AC,表现为出血、高血浆TM、凝血酶生成减弱和纤溶延迟。
- 共遗传的CPB2终止增益变异降低血浆TAFI水平但无症状,使纤溶延迟部分减轻。
- TAFI缺陷未改变TM-AC相关的凝血酶生成缺陷。
核心结论
- 这些数据扩展了TM-AC的已知遗传变异谱,并确立由血浆TM胞外域水平升高引起的共同分子发病机制。
- 数据进一步证实TM-AC相关的纤溶延迟与TAFI活化增加直接相关。
- 家系成员中罕见变异的组合为理解凝血酶-TM系统及其对TAFI的调节提供了独特的遗传模型。
研究设计与样本
- 通过下一代测序鉴定止血基因中的致病变异,并进行病例召回以进行深度表型分析。
主要发现
- 携带先前报道的THBD变异(预测p.Pro496Argfs*10及TM跨膜域链截短)的家系成员有异常出血和血浆TM水平大幅升高。
- 受累病例凝血酶生成减弱和纤溶延迟,与先前报道的THBD p.Cys537* TM-AC病例相似。
- 部分家系成员还携带CPB2终止增益变异,降低血浆TAFI水平但无症状。
- 同时携带p.Pro496Argfs*10 THBD变异导致TM-AC和TAFI缺陷的家系成员纤溶延迟部分减轻,但凝血酶生成缺陷无变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Thrombomodulin-associated coagulopathy (TM-AC) is a rare bleeding disorder in which a single reported p.Cys537* variant in the thrombomodulin gene THBD causes high plasma thrombomodulin (TM) levels. High TM levels attenuate thrombin generation and delay fibrinolysis. OBJECTIVES: To report the characteristics of pedigree with a novel THBD variant causing TM-AC, and co-inherited deficiency of thrombin-activatable fibrinolysis inhibitor (TAFI). PATIENTS/METHODS: Identification of pathogenic variants in hemostasis genes by next-generation sequencing and case recall for deep phenotyping. RESULTS: Pedigree members with a previously reported THBD variant predicting p.Pro496Argfs*10 and chain truncation in TM transmembrane domain had abnormal bleeding and greatly increased plasma TM levels. Affected cases had attenuated thrombin generation and delayed fibrinolysis similar to previous reported TM_AC cases with THBD p.Cys537*. Coincidentally, some pedigree members also harbored a stop-gain variant in CPB2 encoding TAFI. This reduced plasma TAFI levels but was asymptomatic. Pedigree members with TM-AC caused by the p.Pro496Argfs*10 THBD variant and also TAFI deficiency had a partially attenuated delay in fibrinolysis, but no change in the defective thrombin generation. CONCLUSIONS: These data extend the reported genetic repertoire of TM-AC and establish a common molecular pathogenesis arising from high plasma levels of TM extra-cellular domain. The data further confirm that the delay in fibrinolysis associated with TM-AC is directly linked to increased TAFI activation. The combination of the rare variants in the pedigree members provides a unique genetic model to develop understanding of the thrombin-TM system and its regulation of TAFI.
引用
- Westbury SK, Whyte CS, Stephens J, et al. A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by co-inherited TAFI deficiency. J Thromb Haemost. 2020. PMID: 32634856. doi:10.1111/jth.14990
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。